Information Library

Results for: Clinical and marketing materials - Late Phase - Lifecycle Safety

To learn more about Quintiles’ services, you may broaden or narrow your search by selecting the topics at left.

Start Over

  • Sort by:
  • Recently Added
  • Title

  • Clinical – Smarter Trials, Accelerated Outcomes

    Brochure — February 16, 2011
    Quintiles will work with you to plan and execute the smartest clinical trials and post-marketing studies, informed by a holistic view of strategic, operational, regulatory and marketplace issues.

  • Oversight Group Management Services - Aligned Action

    Brochure — February 2, 2011
    From data monitoring committees and endpoint adjudication to core laboratory oversight, Quintiles provides a one-stop solution for managing oversight groups.

  • The New Health Clinical Brochure

    Brochure — August 31, 2010
    Japanese version available for download.

  • Risk Mitigation Programs

    Brochure — April 16, 2009
    Risk mitigation measures can help keep valuable drugs on the market, even when their safety profile includes adverse events that might negatively affect the benefit risk balance.

  • Risk Assessment & Strategy

    Brochure — April 16, 2009
    Quintiles benefit risk analysis can help you anticipate potential regulatory concerns and highlight the benefit side of your drug’s benefit risk profile.

  • Phase IIIb/IV Studies

    Brochure — April 16, 2009
    New, more efficient delivery models help meet the increasing demands of Phase IIIB/IV Studies.

  • Late Phase and Safety Services

    Brochure — April 10, 2009
    Recent and pending regulatory changes have created an atmosphere of watchful waiting throughout the industry. While it may seem premature to initiate post-marketing studies to collect more “intelligent” safety data, Quintiles Late Phase & Safety Services anticipates that the need for expanded studies will soon spread.

Page 1 of 1 (7 results)

Subscribe to Email Based on Your Interests

Set preferences